Synergistic effects of melatonin and other biological molecules on breast cancer MCF-7 cell functions: possible implications in anticancer therapy by Margheri, Martina et al.
IJAE Vol. 115, n. 1/2 (Supplement), 2010
105
Synergistic effects of melatonin and other biological 
molecules on breast cancer MCF-7 cell functions: 
possible implications in anticancer therapy
Martina Margheri1, Alessia Tani1, Aida Dama1, Fabio Francini2, Roberta Squecco2, Nicola Pacini1
1 Department of Anatomy, Histology and Forensic Medicine, University of Florence, Italy
2 Department of Physiological Sciences, University of Florence, Italy
In the recent years, the antineoplastic action of melatonin has been extensively de-
scribed, including oncostatic effects on different tumors and improvement of chemo-
therapeutic regimens. However, the mechanisms underlying these phenomena remain 
unclear and a matter of debate.
The aim of the present study was to further investigate the effects of melatonin, 
administered alone or in combination with other molecules, such as somatostatin and 
retinoic acid, on MCF-7 human breast cancer cells, in terms of cell viability, proliferation 
and death. 
Melatonin 1 µM, 10 µM, 100 µM was administered for 24, 48, 72 hours. It was found 
that melatonin induced a dose and time-dependent inhibition of cell viability, as judged 
by MTS assay. This effect was particularly evident at pharmacologic concentration and 
was greatly potentiated when melatonin was given in association with somatostatin and 
retinoic acid, suggesting a synergistic effect of these molecules. We also showed that the 
reduced cell viability in the cells treated with the highest concentration of melatonin, 
either alone or in combination with somatostatin and retinoic acid, was associated with 
alteration in the cell cycle, with a reduced number of cells expressing cyclin A. Consist-
ent with these latter data, the treated cells showed alteration in Notch/ Jagged signal-
ling and a significant induction of necrotic cell death.
The electrical properties of the treated cells were also analyzed by whole patch clamp 
in voltage- clamp condition. Melatonin induced a decrease of the fast delayed rectifier 
K+ current and an increase of the slower activating Ca2+-dependent K+ current. Such 
effects were potentiated when melatonin was given in association with somatostatin 
and retinoic acid.
Taken together, these findings demonstrate, for the first time, that the oncostatic ef-
fect of melatonin on MCF-7 cells may be greatly increased by its association with so-
matostatin and retinoic acid and suggest that these effects are related, at least in part, 
to changes in the K+ channels type expression and functionality, in cyclin A expression 
and Notch pathway. These novel findings rise the intriguing hypothesis that melatonin 
in association with somatostatin and retinoic acid might prove helpful as adjuvant in 
breast cancer therapy.
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